U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over 170 points and ending the day at 19,338.29. The Dow decreased by almost 0.2% to 43,153.13, while the S&P 500 fell 0.2% to 5,937.34.

These are the top stocks that gained the attention of retail traders and investors throughout the day:

Apple Inc. (NASDAQ:AAPL)

Apple’s shares fell 4.04%, closing at $228.26, with an intraday high of $238.01 and a low of $228.03. The stock is trading between its 52-week high of $260.09 and low of $164.08. The decline follows a report indicating a significant drop in iPhone sales in China, with Canalys data showing a 17% annual decrease in shipments, marking Apple’s largest sales drop in the region.

Rivian Automotive Inc. (NASDAQ:RIVN)

Rivian’s stock rose 3.59% to close at $14.44, reaching an intraday high of $14.66 and a low of $13.95. The stock’s 52-week range is $18.86 to $8.26. The increase came after Rivian finalized a loan agreement with the U.S. Department of Energy for up to $6.6 billion, aimed at supporting the construction of a new manufacturing facility in Georgia.

UnitedHealth Group, Inc. (NYSE:UNH)

UnitedHealth shares dropped 6.04%, closing at $510.59, with a high of $539.84 and a low of $510. The stock’s 52-week high is $630.73, and the low is $436.38. The decline follows mixed financial results, with earnings exceeding estimates but revenue falling short by nearly $1 billion, amid challenges like Medicare funding reductions.

Biomerica, Inc. (NASDAQ:BMRA)

Biomerica’s stock surged 101.71% to $0.71, with an intraday high of $1.27 and a low of $0.56. The stock’s 52-week range is $1.35 to $0.24. The dramatic rise follows the approval of its Fortel Prostate Specific Antigen Screening Test by the United Arab Emirates Ministry of Health and Prevention.

Tesla Inc. (NASDAQ:TSLA)

Tesla’s shares decreased by 3.36%, closing at $413.82, with a high of $424 and a low of $409.13. The stock trades between a 52-week high of $488.54 and a low of $138.8. The decline comes as an analyst from Goldman Sachs highlighted Tesla’s monetization opportunities with robotaxis and full self-driving technology, maintaining a Neutral rating.

Prepare for the day’s trading with top premarket movers and news by Benzinga.